Goodwin

Gozde Guckaya

Deals
6
Latest
Jul 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 6 deals
Deals by year
Gozde Guckaya: deals by year03620252026 YTD: 6 M&A62026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Gozde Guckaya was named on, most recent first
Jul 2026 Memo Therapeutics –IpsenAcquisitionLegal adviser to Memo Therapeutics AG (target)Announced231.1BiotechIpsen acquisition of Memo Therapeutics
May 2026 Perfuse Therapeutics –BayerAcquisitionLegal adviser to Perfuse Therapeutics (target)Announced300.0Biotech+2Bayer acquisition of Perfuse Therapeutics
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionLegal adviser to Tubulis (target)Announced3,150.0Biotech+2Gilead Sciences acquisition of Tubulis
Mar 2026 Ouro Medicines –GileadAcquisitionLegal adviser to Ouro Medicines (target)Announced1,675.0Biotech+1Gilead acquisition of Ouro Medicines
Mar 2026 Pikavation SynnovationNovartisAcquisitionLegal adviser to Synnovation Therapeutics (seller)Announced2,000.0Biotech+2Novartis acquisition of Pikavation
Feb 2026 Laysan Bio –Gannet BioChemAcquisitionLegal adviser to Gannet BioChem (acquirer)Announced–Pharma Services+2Gannet BioChem acquisition of Laysan Bio

Deals where Gozde Guckaya is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.